ZURICH, April 22 (Reuters) - Roche, the world's biggest maker of cancer drugs, reported a 3 percent rise in sales in the first quarter on Wednesday, with growth held back by a strong Swiss franc.
The Basel-based firm said sales in the first three months rose to 11.833 billion Swiss francs ($12.40 billion) from 11.496 billion year-ago. This beat analyst views, which averaged 11.492 billion in a Reuters poll.
18:05 DP World, Quebec's Caisse to create C$5 billion investment vehicle10
15:14 Russia central bank: hackers stole over 2 billion roubles from accounts in central bank10
14:45 Spain raises taxes to try to meet EU deficit target12
06:52 France's Carrefour eyes second-quarter 2017 4.5 billion euros IPO of Carmila arm: report13